These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5612658)

  • 1. [Experiences with an internal treatment method in inflammatory and ulcerative disorders of the gastric and intestinal mucosa].
    Zwerenz G
    Landarzt; 1967 Oct; 43(29):1431-3. PubMed ID: 5612658
    [No Abstract]   [Full Text] [Related]  

  • 2. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with Medazepam in gestrointestinal diseases].
    Venhofen JM; Weiss D
    Arzneimittelforschung; 1968 Dec; 18(12):1569-70. PubMed ID: 5756252
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of xylamide on the gastric and duodenal mucosa].
    Galeone M; Fichera G
    Minerva Gastroenterol; 1972; 18(4):183-9. PubMed ID: 4680178
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study on the use of phentonium in hypersecretive and ulcerative gastroduodenal diseases].
    Azzollini F; Fichera G
    Clin Ter; 1972 Nov; 63(3):259-67. PubMed ID: 4644530
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of gastritis and gastro-duodenal ulcers with drugs with predominantly spasmolytic and vasodilating action].
    Cascone A; Ferrari F
    Minerva Gastroenterol; 1969; 15(2):60-77. PubMed ID: 4389365
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Data on the therapeutic use of vitamin U].
    Varga D
    Ter Arkh; 1974; 46(4):84-9. PubMed ID: 4428375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Local treatment of non-healing gastroduodenal ulcers with solcoseryl].
    Kan Ch; Saidmuradova A; Kravchenko LIa; Mishanina ZG
    Klin Med (Mosk); 1988 Jan; 66(1):81-4. PubMed ID: 3361822
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa.
    Johansson C; Kollberg B
    Scand J Gastroenterol Suppl; 1980; 58():93-7. PubMed ID: 6988944
    [No Abstract]   [Full Text] [Related]  

  • 11. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the pathogenesis and treatment of erosive gastritis and duodenitis].
    Vakhrushev IaM; Nikishina EV
    Klin Med (Mosk); 1999; 77(2):28-31. PubMed ID: 10380457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of peptic ulcer patients with pantothenic acid].
    Mochalkin NI
    Vrach Delo; 1966 Aug; 8():115-6. PubMed ID: 5989128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of mucosal protection of peptic ulceration and its clinical therapeutic application].
    Novis B; Samara M
    Harefuah; 1984 Nov; 107(10):308-10. PubMed ID: 6530177
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of halidor on the various pathologic processes of the gastrointestinal mucous membrane.
    Dvorský A
    Ther Hung; 1968; 16(1):21-7. PubMed ID: 5651017
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins, gastroduodenal ulcer and hemorrhagic gastritis.
    Bright-Asare P; Whiten JT
    Clin Physiol Biochem; 1984; 2(2-3):101-10. PubMed ID: 6333308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs, gastritis, and peptic ulcer.
    Ivey KJ
    J Clin Gastroenterol; 1981; 3(Suppl 2):29-34. PubMed ID: 7320467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
    Danelius M; Ost A; Lapidus AB
    Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcers and gastritis.
    Pang SH; Leung WK; Graham DY
    Endoscopy; 2008 Feb; 40(2):136-9. PubMed ID: 18058616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.